Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |